Atossa Therapeutics names Heather Rees as CFO
Atossa Therapeutics Inc (NASDAQ:ATOS) has appointed Heather Rees as its new Chief Financial Officer (CFO). The move marks a promotion for Rees, who previously served as the company's senior vice president of finance and principal accounting officer.
Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?
Here is how Atossa Genetics Inc. (ATOS) and Ocugen (OCGN) have performed compared to their sector so far this year.
Atossa Therapeutics to support AI-based breast cancer risk study
Atossa Therapeutics Inc (NASDAQ:ATOS). (Nasdaq: ATOS) has announced its support for the SMART (Stockholm MAmmography Risk stratified Trial) study, a new Phase 2 clinical trial aimed at validating an innovative artificial intelligence-driven breast cancer risk assessment model.
3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off
Amid the rise of the digital innovation space, investors may want to consider biotech stocks to buy. Fundamentally, a rotation into the sector may occur, boding well for the ecosystem before the summer rally kicks off.
